Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Nonviral Transfer Technology
  • Published:

Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer

Abstract

This study demonstrates in vivo effectiveness of a nonviral vector system, Epstein–Barr virus (EBV)-based plasmid vector coupled with polyamidoamine (PAMAM) dendrimer (EBV/polyplex), in suicide gene therapy of cancer. The EBV-based vector is a plasmid vector containing EBV nuclear antigen 1 (EBNA1) gene and oriP from EBV genome. HSV-1 tk gene was transferred into Ewing's sarcoma cell lines, A4573 and KP-EWS-YI, by using an EBV-based plasmid vector, pSES.Tk, or a conventional plasmid vector, pS.Tk. Cells transfected with pSES.Tk/dendrimer showed approximately 100 times lower ID50 to ganciclovir (GCV) compared with those transfected with pS.Tk/dendrimer. Intratumoral injection of pSES.Tk/dendrimer but not pS.Tk/dendrimer drastically suppressed the growth of tumors which had generated from A4573 or Huh7 hepatocellular carcinoma (HCC) cells inoculated into severe combined immunodeficiency (SCID) mice. The treatment with pSES.Tk/dendrimer also resulted in significant prolongation of survival of the mice implanted with A4573. These results suggest that the EBV/polyplex system could be useful for in vivo suicide gene therapy of cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Felgner PL, Ringold GM . Cationic liposome-mediated transfection Nature (Lond) 1989 373: 387–388

    Article  Google Scholar 

  2. Tang MX, Redemann CT, Szoka FC . In vitro gene delivery by degraded polyamidoamine dendrimers Bioconjugate Chem 1996 7: 703–714

    Article  CAS  Google Scholar 

  3. Kukowska-Latallo JF et al. Efficient transfer of genetic material into mammalian cells using starburst polyamidoamine dendrimers Proc Natl Acad Sci USA 1996 93: 4897–4902

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Satoh E et al. Efficient gene transduction by Epstein–Barr virus-based vectors coupled with cationic liposome and HVJ-liposome Biochem Biophys Res Commun 1997 238: 795–799

    Article  CAS  PubMed  Google Scholar 

  5. Hirai H et al. Use of EBV-based vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms Biochem Biophys Res Commun 1997 241: 112–118

    Article  CAS  PubMed  Google Scholar 

  6. Harada Y et al. Highly efficient suicide gene expression in hepatocellular carcinoma cells by Epstein–Barr virus-based plasmid vectors combined with polyamidoamine dendrimer Cancer Gene Ther (in press)

  7. Yates JL, Warren N, Sugden B . Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells Nature (Lond) 1985 313: 812

    Article  CAS  Google Scholar 

  8. Mazda O, Satoh E, Yasutomi K, Imanishi J . Extremely efficient gene transduction into lympho-hematopoietic cell lines by Epstein–Barr virus-based vectors J Immunol Meth 1997 204: 143–151

    Article  CAS  Google Scholar 

  9. Satoh E et al. Successful transfer of ADA gene in vitro into human peripheral blood CD34+ cells by transfecting EBV-based episomal vectors FEBS Lett 1998 441: 39–42

    Article  CAS  PubMed  Google Scholar 

  10. Atzpodien J et al. Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing Oncology 1988 45: 437–443

    Article  CAS  PubMed  Google Scholar 

  11. Sommadossi JP et al. Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function Rev Infect Dis 1988 10 (Suppl 3): S507–S514

    Article  PubMed  Google Scholar 

  12. Izuquierdo M et al. Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy Gene Therapy 1996 3: 491–495

    Google Scholar 

  13. Ram Z et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells Nature Med 1997 3: 1354–1361

    Article  CAS  PubMed  Google Scholar 

  14. Klatzmann D et al. Study group on gene therapy of metastatic melanoma. A phase I/II dose-escalation study of herpes simplex virus type 1 thymidine kinase ‘suicide’ gene therapy for metastatic melanoma Hum Gene Ther 1998 9: 2585–2594

    CAS  PubMed  Google Scholar 

  15. Sterman DH et al. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma Hum Gene Ther 1998 9: 1083–1092

    Article  CAS  PubMed  Google Scholar 

  16. Judde JD, Spangler G, Magrath I, Bhatia K . Use of Epstein–Barr virus nuclear antigen-1 in targeted therapy of EBV-associated neoplasia Hum Gene Ther 1996 7: 647–653

    Article  CAS  PubMed  Google Scholar 

  17. Evans TJ, Brooks L, Farrell PJ . A strategy for specific targeting of therapeutic agents to tumor cells of virus-associated cancers Gene Therapy 1997 4: 264–267

    Article  CAS  PubMed  Google Scholar 

  18. Kenny S, Ge J-Q, Westphal EM, Olsen J . Gene therapy strategies for treating Epstein–Barr virus-associated lymphomas: comparison of two different Epstein–Barr virus-based vectors Hum Gene Ther 1998 9: 1131–1141

    Article  Google Scholar 

  19. Tomalia DA, Durst HD . Supramolecular chemistry I-directed synthesis and molecular recognition Topics Curr Chem 1993 165: 193

    Article  CAS  Google Scholar 

  20. Singh P et al. Starburst dendrimers: enhanced performance and flexibility for immunoassays Clin Chem 1994 40: 1845–1849

    CAS  PubMed  Google Scholar 

  21. Bielinska AU et al. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers Nucleic Acids Res 1996 54: 2176–2182

    Article  Google Scholar 

  22. Qin L et al. Efficient transfer of genes into murine cardiac grafts by starburst polyamidoamine dendrimers Hum Gene Ther 1998 9: 553–560

    Article  CAS  PubMed  Google Scholar 

  23. Freeman S et al. The ‘bystander effect’: tumor regression when a fraction of the tumor mass is genetically modified Cancer Res 1993 53: 5274–5283

    CAS  PubMed  Google Scholar 

  24. Pope IM, Poston GJ, Kinsella AR . The role of bystander effect in suicide gene therapy Eur J Cancer 1997 33: 1005–1016

    Article  CAS  PubMed  Google Scholar 

  25. Sirac-Dilber M, Edvard-Smith CI . Suicide genes and bystander killing: local and distant effects Gene Therapy 1997 4: 273–274

    Article  Google Scholar 

Download references

Acknowledgements

We thank F Hoffmann-La Roche Ltd (Basel, Switzerland) for kindly providing us with GCV. We also thank Ms Satoko Watanabe (Department of Microbiology, Kyoto Prefectural University of Medicine) for her excellent secretarial assistance. This research was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture, Japan, and the Japan Heart Foundation and IBM Japan Research Grant.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maruyama-Tabata, H., Harada, Y., Matsumura, T. et al. Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer. Gene Ther 7, 53–60 (2000). https://doi.org/10.1038/sj.gt.3301044

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301044

Keywords

This article is cited by

Search

Quick links